64-Cu-DOTA-BFab

N/A

Report date: 2025/09/25 17:56:51

Base Information

Drug Name64-Cu-DOTA-BFab

Drug Alias NameCA6-targeting PET tracer (Sanofi/Stanford University)64Cu-DOTA B-Fab

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionCarbonic anhydrase VI modulators

TargetsCarbonic anhydrase VI

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi Aventis

China Registration ClassN/A

Develop Information

Active CompaniesSanofi Aventis Stanford University

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A